Literature DB >> 16374699

A case of myocardial infarction with sumatriptan use.

E Erbilen1, H Ozhan, R Akdemir, M Yazici.   

Abstract

Sumatriptan is widely used in the treatment of acute attacks of cluster headache. It is a serotonin-1 (5HT-1) agonist. Several studies have reported an association between sumatriptan use and myocardial infarction, possibly due to the generalized vasoconstrictive nature of this agent. We report a 16-year-old male patient presenting with acute inferior myocardial infarction after sumatriptan use without any known risk factors of coronary artery disease.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16374699     DOI： 10.1007/s00246-004-0768-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  8 in total

1.  Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients.

Authors:  W H Visser; N M Jaspers; R H de Vriend; M D Ferrari
Journal:  Cephalalgia       Date:  1996-12       Impact factor: 6.292

2.  5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation.

Authors:  H E Connor; W Feniuk; P P Humphrey
Journal:  Eur J Pharmacol       Date:  1989-02-14       Impact factor: 4.432

3.  Oral sumatriptan-associated transmural myocardial infarction.

Authors:  P O'Connor; P Gladstone
Journal:  Neurology       Date:  1995-12       Impact factor: 9.910

4.  Transmural myocardial infarction with sumatriptan.

Authors:  J P Ottervanger; H J Paalman; G L Boxma; B H Stricker
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

5.  Characteristics and determinants of sumatriptan-associated chest pain.

Authors:  J P Ottervanger; H A Valkenburg; D E Grobbee; B H Stricker
Journal:  Arch Neurol       Date:  1997-11

6.  Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation.

Authors:  P D MacIntyre; B Bhargava; K J Hogg; J D Gemmill; W S Hillis
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

7.  Vasospasm-induced myocardial infarction with sumatriptan.

Authors:  L Mueller; R M Gallagher; C A Ciervo
Journal:  Headache       Date:  1996-05       Impact factor: 5.887

8.  Cardiac arrest following use of sumatriptan.

Authors:  K M Kelly
Journal:  Neurology       Date:  1995-06       Impact factor: 9.910
  8 in total
  2 in total

Review 1.  The use of triptans for pediatric migraines.

Authors:  Lea S Eiland; Melissa O Hunt
Journal:  Paediatr Drugs       Date:  2010-12-01       Impact factor: 3.022

2.  Triptans and troponin: a case report.

Authors:  Claudia R Weder; Markus Schneemann
Journal:  Orphanet J Rare Dis       Date:  2009-06-18       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.